|Número de publicación||WO1990013666 A1|
|Tipo de publicación||Solicitud|
|Número de solicitud||PCT/GB1990/000726|
|Fecha de publicación||15 Nov 1990|
|Fecha de presentación||11 May 1990|
|Fecha de prioridad||11 May 1989|
|También publicado como||CA2045505A1, EP0471732A1|
|Número de publicación||PCT/1990/726, PCT/GB/1990/000726, PCT/GB/1990/00726, PCT/GB/90/000726, PCT/GB/90/00726, PCT/GB1990/000726, PCT/GB1990/00726, PCT/GB1990000726, PCT/GB199000726, PCT/GB90/000726, PCT/GB90/00726, PCT/GB90000726, PCT/GB9000726, WO 1990/013666 A1, WO 1990013666 A1, WO 1990013666A1, WO 9013666 A1, WO 9013666A1, WO-A1-1990013666, WO-A1-9013666, WO1990/013666A1, WO1990013666 A1, WO1990013666A1, WO9013666 A1, WO9013666A1|
|Inventores||Peter Bryan Garland, Paul James Heaney, Denise Vera Pollard-Knight|
|Solicitante||Amersham International Plc|
|Exportar cita||BiBTeX, EndNote, RefMan|
|Citas de patentes (4), Citada por (179), Clasificaciones (6), Eventos legales (7)|
|Enlaces externos: Patentscope, Espacenet|
Determination of the sequence of nucleotide bases in 2 ' -deoxyribonucleic acid (DNA) and to a lesser extent ribonucleic acid (RNA) is a central technology for much of present day molecular biology and its many applications. There are currently two main methods available for sequencing DNA, and both involve using a DNA polymerase enzyme to make a copy of a suitably primed strand of the unknown DNA which acts as a template. In the so-called chain-termination method of Sanger et al (1977), the growing copy strand is randomly (at least, randomness is intended) terminated by incorporation of a 2' , 3 ' -dideoxyribonucleotide (ddNTP) competing with the normal 2'- deoxyribonucleotide (dNTP) for addition to the 3'-end of the growing copy strand. By using suitable conditions and four separate preparations corresponding to dATP with ddATP, dCTP with ddCTP, dGTP with ddGTP and dTTP with ddTTP, all possible lengths of terminated copy strands are available. They are separated by size by gel electrophoresis, and detected by means of an incorporated label, commonly radioactive but more recently fluorescent (Smith et al , 1986; Ansorge et al , 1987). The DNA sequence of the copy, and therefore the complementary sequence of the template, is derived from the pattern of chain lengths detected for the separate A, C, G and T termination mixture.
The chemical degradation method of Maxa and Gilbert (1977) also uses DNA polymerase catalysed formation cf a template-copy. The dNTP ' s are radio-
32 35 active with P (or S) at the α-position, so the copy is also radioactive. Chemical treatments specific for different bases cleave the copy into sets of fragments which, as with the Sanger dideoxy chain termination method, can be separated by gel electrophoresis and detected (by autoradiography) to yield patterns from which the DNA sequence can be deduced. Variants of these methods have been described (Church & Kieffer- Higgins, 1988; Gish and Eckstein, 1988), but are still dependent upon gel electrophoresis to separate DNA fragments, and upon such methods such as radiolabel ling for detection of the separated fragments.
All of these methods are slow, complex and expensive in relation to the needs for DNA sequencing. For example, the best rates of DNA sequencing to date are about 600 nucleotides in 12 hours, using an automated instrument (Landegran et al, 1988). This corresponds to 50 bases per hour or 0.014 bases per sec. This rate is approximately two-orders of magnitude lower than that thought necessary for large- scale sequencing in the Human Genome Project (Alberts et al, 1988).
Three laboratories have reported attempts to avoid the needs for copy-strand fragments and their length-determination by gel electrophoresis. Hyman (1988) immobilised the DNA template primer with polymerase on an ion-exchange material and exposed the complex to a flow wherein only one of the four dNTP's was present at a time. A downstream detection system then detected the pyrophosphate liberated in the DNA polymerase reaction:- template - primer + dNTP -> template - (primer + dNMP) + PPi where dNMP stands for the added nucleotide residue, PPi for pyrophosphate. The sequencing rate was approximately 1 base every 10 minutes. Melamede (1987) also proposed the use of an immobilised DNA template, primer and polymerase complex exposed to a flow containing only one species of dNTP at a time. However, incorporation of dNTP into the copy was calculated not from measurements of pyrophosphate release but from the difference in dNTP concentrations entering and leaving the flow cell which contains the complex of DNA template and polymerase. No experimental data were presented.
Jett (1989) provided a single stranded DNA or RNA sequence of labelled nucleotides, complementary to the sequence to be determined, suspended in a moving flow stream. An exonuclease sequentially cleaved individual basis from the end of the suspended sequence. The resulting train of individual labelled nucleotides was passed to a downstream location for analysis of the individual nucleotides. This invention
As with the methods of Melamede (1987) and Hyman (1988), we also use an immobilised complex of template and primer, exposed to a flow containing only one dNTP at a time. We differ however in that we directly measure the growth of the template copy, rather than infer it indirectly from changes in the composition of the flow medium. The methods of detection are preferably spectroscopic and do not require the further addition of chemical reagents to effect measurement of template-copy growth. The spectroscopic methods are:- i) Evanescent wave spectroscopy ii) Fluorescence detection (non-evanescent wave) iii) Absorption spectroscopy (non-evanescent wave) Alternatively the individual nucleotides may be labelled, e.g. radioactively. Attachment of each successive labelled nucleotide to the immobilised complex is then detected by an increase in total radioactivity. Irrespective of which detection method is used, the time-dependent signal arising from polymerase catalysed template copy growth depends on the availability of the correct (i.e. complementary) nucleotide for base-pairing with the template at the growing point of the copy. If all four nucleotides are absent, there is no polymerase activity. If only one nucleotide is present, then extension of the copy will occur only as far as base-pairing with the template is possible in the absence of the other three nucleotides. Preferably a continuous flow of pulses of deoxynucleotides (dATP, dCTP, dGTP, dTTP) or ribonucleotides (ATP, CTP, GTP, UTP)or analogues of these nucleotides, each separated by a wash pulse, is passed over the tethered template DNA or RNA (with any extension and linkers, and the primer oligonucleotide). This is done under conditions, e.g. in the presence of a suitable polymerase enzyme, to cause an extension of the primer by addition of the nucleotide (or analogue) to the 3'-end of the primer if the nucleotide (or analogue) is complementary to and can hybridize with the next free nucleotide of the template (going from the 3'-end towards the 5'-end). Conditions of solvent, temperatures, ionic strength and concentrations of any polymerase enzyme activating cations and anioπs are maintained such that the polymerase is enzymatical ly active in the presence of its substrates. Because only one of the four nucleotides is present at a time, extension of the copy strand occurs in jumps depending on whether the appropriate nucleotide for pairing with the next unpaired base of the template strand is present or not. Each such jump is herein designated a polymerisation event. Thus the signal also exhibits time-dependent jumps that reflect the extension jumps (polymerisation events) of the copy strand. Furthermore, the size of the signal jumps is proportional to the number of bases added in each extension jump (i.e. proportional to the number of polymerisation events), e.g. the addition of say three adenine residues gives three times the signal given by the addition of only one such residue. Because the copy strand can be extended by only an integral number of bases (0, 1 , 2, 3— ) during any extension jump, then the optical signals are quantised. This property of the signals is highly advantageous for calibration and for discrimination against noise. For simplicity, this invention is hereafter described in terms of DNA sequencing, using a DNA template with DNA polymerase and deoxynucleotides (dNTP's) or analogues to make a DNA copy. It should be noted that RNA technologies could be used : e.g. (i) DNA as the template, RNA polymerase to make an RNA copy (ii) RNA as the template, reverse transcriptase to make a DNA copy, and (iii) RNA as the template, RNA replicase to make an RNA copy. ( ) Evanescent wave spectroscopy (EWS) Evanescent wave spectroscopy is defined in the present context as embracing three related methods: (i) attenuated total reflection (ATR) spectroscopy (ii) total internal reflectance fluorescence (TIRF) spectroscopy, and (iii) surface plasmon resonance (SPR) spectroscopy. Each of these three spectroscopic techniques examines an optical property of a solution bordering a surface where total internal reflection of a light beam has occurred. In each case the incident and reflected beams are on the side of the surface distal to (i.e. remote from) the solution under study, whereas the evanescent wave is established on the solution side of the surface but extends into that solution for a very short distance, typically less than the wavelength of the incident/reflected beam. Spectroscopy by ATR or TIRF requires only a transparent material such as glass or quartz to create the interfacial surface with the solution, whereas SPR spectroscopy requires that the glass or quartz surface be coated with a thin (e.g. 50nm) metal layer of, for example, silver. All three methods can detect the exchange of solute molecules between the bulk phase of the solution and the interfacial surface, albeit by different means. ATR spectroscopy detects the absorption of evanescent wave light by molecules, with appropriate absorption spectra, that lie within the evanescent wave region. If the absorbed light is re- emitted as fluorescence then the emission can be measured with a suitable detector, such as a photo- multiplier tube, leading to TIRF spectroscopy. Thus both ATR and TIRF spectroscopy measure the absorption of light by molecules at or close to the interfacial surface, the difference being that ATR measures the absorption directly whereas TIRF measures it indirectly, as re-emitted fluorescence. By contrast, SPR spectroscopy measures changes of refractive index that may occur in the SPR evanescent wave region, but, just as with ATP and TIRF, those changes arise due to redistribution of molecules between the bulk phase of the solution and the evanescent wave region. For a review of these methods, see Sutherland and Dahne, 1987.
Having given a brief outline of evanescent wave spectroscopies , we can describe their application to DNA sequencing. The DNA molecule of unknown sequence, derived from biological techniques such as DNA cloning or polymerase chain reactions must (i) be single stranded (ii) be attached either directly or indirectly by either its 31 or 5' end to the interfacial surface of an EWS device, and (iii) possess a known sequence, either naturally occurring or added, at its 3' end such that a complementary oligonucleotide (primer) can be hybridised to create a run of double stranded DNA. Thus in the presence of DNA polymerase and deoxyribonucleotide triphosphates (dNTP) the unknown DNA acts as a template for the synthesis of a complementary copy extending by growth from the 3' end of the primer. DNA polymerase catalysed growth of the template copy results in recruitment of dNTP's from the bulk phase to the interfacial region where the template is tethered. It is assumed that the copy strand remains base-paired to the template strand, and does not diffuse away. Template copy growth can therefore be measured by EWS spectroscopy. ATR spectroscopy requires that the incident beam be in the wavelength region of a major absorption band of the dNTP's, typically about 260nm. TIRF spectroscopy requires that the nucleosides incorporated into the template copy can be excited to fluoresce by the evanescent wave : fluorescent DNTP analogues are required. SPR spectroscopy has fewer limitations : dNTP analogues are not required (although substitution with refractive index enhancing atoms such as Br, I or Hg might be advantageous for sensitivity) and the choice of wavelength is not critical.
Figure 1 illustrates the experimental set up, shown for the specific case of SPR spectroscopy. The 3' end of the template DNA (or its extension) is attached to the interfacial silver surface, and the primer oligonucleotide is hybridised to the template. Alternatively the primer could be attached to the surface and the template DNA hybridised to the primer. Clearly the polarity of attachment can be reversed:- the 5' end of the template bound to the surface, and the primer hybridised to the free 3' end of the template or extension.
Figure 2 shows idealised experimental results using SPR spectroscopy. The sequence of the template being copied is read directly from the associations between jumps in the EWS signal and the particular dNTP pulse present at the template site, (ii ) Fluorescence detection
Because each cycle of dNTP (or rather its fluorescent analogue) is preceded and followed by a wash, EWS (TIRF) is not mandatory to distinguish the fluorescence signal arising from the template-copy from free nucleotides in the medium. Thus a more conventional optical geometry can be used, and immobilisation of the template-primer-polymerase complex can be on beads, fibres or membranes rather than an evanescent wave surface.
A serious drawback of the fluorescent method for DNA sequencing, irrespective of whether or not it uses an evanescent wave, is the fact that the absolute size of the signal grows as the copy strand grows. This makes it harder to detect the increments (jumps) of fluorescence resulting from strand extension. Even under ideal conditions (Poissonian photon-counting statistics, zero background and noise-less excitation source), it is necessary to increase the measurement time for each increment of nucleotide addition in proportion to the number of such increments in order to maintain constant sensitivity for the detection of each successive fluorescence increment. For example, if it took 1 sec to measure the fluorescence of the first added nucleotide to a satisfactory accuracy, then 10 seconds would be needed to measure the tenth added nucleotide, 100 seconds for the hundredth, and so on. Thus what is intended to be a fast DNA sequencing method becomes progressively slower as it proceeds.
There are two instrumental solutions to this problem. The first is to increase not the duration of measurement for successive increments of fluorescence, but the excitation intensity. By this means the accumulation of photon counts required for accuracy can be achieved in a constant time. Technically this can be arranged with a CW laser excitation source equipped with an acousto-optic or electro-optic modulator to modify the beam intensity transmitted to the sample. The second solution is to irreversibly photobleach the sample fluorescence with an intense light pulse at periodic intervals, thereby resetting the sample fluorescence to zero before it can significantly degrade the detection of successive increments.
Technically this can also be achieved with a CW laser equipped with a modulator (Garland, 1981).
The fluorescent probe itself can be attached to each of the four dNTP's. As each dNTP is presented separately to the template-primer-polymerase complex, the same fluorophoric group can be used for each dNTP. Alternatively, fluorescent dideoxy chain terminators can be used in competition with unlabelled dNTP's, under conditions where the number of terminated chains s not so large as to deplete the number of unterminated chains to the point where fluorescence increments associated with chain termination become difficult to detect. Each dNTP is presented with its corresponding fluorescently-label led ddNTP to the template-primer-polymerase complex, and a single fluorophore is sufficient, (iii) Absorption spectroscopy
The direct measurement of template copy growth by detecting the increase in ultraviolet light absorption at approximately 250-260nm caused by addition of new nucleotides to the copy strand is not sensitive. However, the availability of relatively large amounts of starting material (template) through DNA cloning or polymerase chain methods, allied to powerful U-V laser sources such as f equency-tripled Nd-Yag lasers, makes it technically possible to measure template-copy growth directly by absorption spectroscopy.
The advantages of these optical methods over existing methods are very large. They include:- - potential for high speed (e.g. 10 bases/sec) miniaturisation and parallel flow lanes no need for gel electrophoresis direct signal transfer to computer no need for radioactive nucleotides - greater chance for complete automation due to absence of gel separation steps.
The following Examples illustrate the invention.
Detection of Polymerase Catalysed Nucleotide Addition on a Silver Slide using Surface Plasmon Resonance
Materials and Methods Reagents
1. 0.25pmole/μl solutions of hybrid DNA (consisting of a 17 nucleotide primer sequence hybridised to a 20, 27 or a 97 nucleotide template sequence) prepared in 10 mM phosphate buffer pH 7.4 containing 10mM phosphate 5 buffer pH 7.4 containing 10mM MgCl and 50mM NaCl.
2. 10mM phosphate buffer pH 7.4 containing 10mM MgCl2 and 50mM NaCl (sequencing phosphate).
3. 10mM phosphate buffer pH 7.4.
4. DNA Polymerase 1 "Klenow fragment" diluted in Q sequencing phosphate containing 250μM dATP, dCTP, dGTP and dTTP.
5. Block solution of 0.05% BSA in sequencing phosphate.
A single beam direct reference rig using a 632.8nm wavelength helium neon laser which interrogated two spots and subtracted one signal from the other, was used. Pump and flow cell
A modified step motor pump which held 2 syringes was used to deliver different or identical solutions to the 2 segregated areas of the flow cell. Si 1ver SI ides
Silver coating thickness on the slides was greater than that normally used for SPR work i.e. 60nm to achieve an SPR width of approximately 0.6 degrees at approximately 5% from the reflectance minimum.
Slide Tolerance Limits
The slides were rejected if the SPR profiles on both areas of the silver slide were not similar in shape and minimum.
1. 1ml 10mM phosphate buffer ph 7.4 was added at 4μl/second to the silver slide.
2. 1ml sequencing phosphate was added at 4μl/second.
3. 1ml of hybrid (17/20 was used as the reference DNA) 17/27 or 17/97 was added at 2μl/second followed by 3 washes in sequencing phosphate. 4- 1ml of BSA block solution was added at 2μl/second followed by 3 x 0.3ml washes in sequencing phosphate. 5. 1ml of Klenow plus nucleotides was added at 2μl/second followed by 3 x 0.3ml washes in sequencing phosphate . Angle and time scans were obtained at strategic points during the experiment. The overall shift difference caused by the addition of extra nucleotides (3 for the reference, 10 for the 17/27 and 80 for the 17/97) was recorded.
The figures in the last column are additional changes over and above those of the 17/20 reference.
The SPR signal obtained from the addition of ten nucleotides to a primer-template complex by the Klenow fragment of DNA polymerase could be measured above the signal obtained from a three nucleotide addition in the reference sample. This clearly demonstrates the detection by SPR of the addition of seven nucleotides.
If the following change is made to the equipment then single nucleotide addition will be detected by SPRS.
The experiments were conducted by recording one reflectivity measurement per second. This gives signal to noise resolution down to seven nucleotides. However by increasing the measurement rate to 1000 per second an improvement by a factor of 30 can be achieved which will permit detection of single nucleotide addition. Noise is proportional to the square root of the number of readings taken, therefore the square root of 1000 equals 30.
Polymerase Catalysed Single Nucleotide Addition to template DNA Immobilised on Silver Slides
Method 1. Template-primer DNA (a 17 nucleotide primer annealed to a 97 nucleotide template) was immobilised
- 13 on the silver slides at a coverage of 1.25 x 10 moles/silver slide.
2. The 4 nucleotide / polymerase mixes were made up as follows in 10mM phosphate buffer pH 7.4 containing 10mm
MgCl and 50mm NaCl:- a) 5μM deoxyadenosine 5 ' -triphosphate + 200U/ml Klenow fragment (Amersham T2141Z), b) 5μM deoxycytidine 5 ' -triphosphate + 200U/ml Klenow fragment, c) 5μM deoxyguanosine 5 ' -triphosphate + 200U/ml Klenow fragment, d) 5μM deoxythymidine 5 ' -triphosphate + 200U/ml Klenow fragment, To each mix 100μCi/ml of the corresponding
P labelled deoxynucleotide triphosphate was added
(Amersham PB204, 205, 206 and 207).
The mixtures a-d were added singly in the sequence in which they appeared in the template strand as follows:- Single nucleotide additions
1. The silver slide was placed on the biosensor he icylinder and its position marked. The flow cell was placed on top of the slide. 2. 3ml of 10mM phosphate buffer pH 7.4 was flowed over the silver slide.
3. 1ml of 10mM phosphate buffer pH 7.4 containing 10mm MgCl and 50mm NaCl was flowed over the silver slide.
4. 100μl of the nucleotide / enzyme mix was injected and left on the silver slide for 5 minutes at room temperature.
5. The silver slide was washed with 5ml of 10mM phosphate buffer pH 7.4 containing 10mm MgCl- and 50mm NaCl + 0.005% Tween 20. 6. The silver slide was removed and blotted to remove any surface fluid then counted on the tritium channel of a scintillation counter.
Incorporation of the deoxynucleotide was determined from the increase in counts on the silver slides and calculated from the specific activity of the nucleotide/polymerase mixture used at that step. The results are shown in Table 1.
7. The silver slide and flow cell were replaced on the biosensor in the same position and steps 3-6 were repeated with the next nucleotide/polymerase mixture until the predetermined nucleotide addition sequence was completed.
Control silver slides were subjected to the same nucleotide addition procedure. Results
Correct Sequence Single Nucleotide Addition to Silver Slide Immobilised DNA
The addition of successive single nucleotides by the Klenow fragment of DNA polymerase 1 to this primer template hybrid immobilised at the silver surface can be observed with radioactively labelled nucleotides.
In the absence of the primer template hybrid no successive increase in nucleotide addition is observed.
Alberts B M, Botstein D, Brenner S, Cantor C R,
Doolittle R F, Hood L, McKusick V A , Nathans D, Olson
M V, Orkin S, Rosenberg L E, Ruddle F H, Tilghman S, Tooze J & Watson J D, (1988). Report of the Committee on Mapping and Sequencing the Human Genome. National
Academy Press, Washington DC.
Ansorge W, Sproat B, Stegemann J, Schwager C & Zenke M,
(1987). Nucleic Acid Res J_5, 4593-4602. Church G M & Kieffer-Higgins S (1988) Science 240,
Garland P B (1987) Biophys. J. 33, 481-482.
Gish G & Eckstein F (1988) Science 2^0, 1520-1522.
Hy an E D (1988) Anal. Biochem. V74-, 423-436. Landegran U, Kaiser R, Caskey CT & Hood L (1988).
Science 242., 229-237.
Maxam A M & Gilbert W (1977). Proc. Natl. Acad. Sci.
(USA) 74., 560-564.
Melamede J (1987) European Patent Application. Publication Number 0 223 618 A2.
Sanger F, Nickless S & Coulson A R (1977). Proc. Natl.
Acad. Sci. (USA) (1987), 7 , 5463-5467.
Sutherland R M & Dahne C (1987) in "Biosensors -
Fundamentals and Applications" (A P F Turner, I Kamber, G S Wilson, eds) pp 655-678. Oxford University Press,
Smith L M, Sanders J Z, Kaiser R J, Hughes P, Dodd C, connell C R, Heiner C, Kent S B H & Hood L E. (1986)
Nature 3jLi» 674-679. Jett J H et al, International Patent Application
WO 89/03432 published 20 April 1989 under the Patent
|Patente citada||Fecha de presentación||Fecha de publicación||Solicitante||Título|
|WO1989003432A1 *||16 Sep 1988||20 Abr 1989||United States Department Of Energy||Method for rapid base sequencing in dna and rna|
|EP0223618A2 *||16 Jul 1986||27 May 1987||New York Medical College||Automatable process for nucleotide sequencing|
|EP0233053A2 *||4 Feb 1987||19 Ago 1987||Applied Biosystems, Inc.||Method of detecting electrophoretically separated oligonucleotides|
|US4770992 *||27 Nov 1985||13 Sep 1988||Den Engh Gerrit J Van||Detection of specific DNA sequences by flow cytometry|
|Patente citante||Fecha de presentación||Fecha de publicación||Solicitante||Título|
|WO1991006678A1 *||26 Oct 1990||16 May 1991||Sri International||Dna sequencing|
|WO1993006241A1 *||16 Sep 1992||1 Abr 1993||The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland||Gene probe biosensor method|
|WO1993021340A1 *||22 Abr 1993||28 Oct 1993||Medical Research Council||Dna sequencing method|
|WO1997004129A1 *||12 Jul 1996||6 Feb 1997||Biacore Ab||Method for nucleic acid sequencing|
|WO1997027331A2 *||23 Ene 1997||31 Jul 1997||Rapigene, Inc.||Methods and compositions for determining the sequence of nucleic acid molecules|
|WO1997027331A3 *||23 Ene 1997||2 Abr 1998||Darwin Molecular Corp||Methods and compositions for determining the sequence of nucleic acid molecules|
|WO1997047761A1 *||13 Jun 1997||18 Dic 1997||Sarnoff Corporation||Method for polynucleotide sequencing|
|WO1998039485A2 *||5 Mar 1998||11 Sep 1998||The Regents Of The University Of Michigan||Compositions and methods for analysis of nucleic acids|
|WO1998039485A3 *||5 Mar 1998||25 Feb 1999||John P Langmore||Compositions and methods for analysis of nucleic acids|
|WO1999005315A2 *||24 Jul 1998||4 Feb 1999||Medical Biosystems Ltd.||Nucleic acid sequence analysis|
|WO1999005315A3 *||24 Jul 1998||22 Abr 1999||Daniel Henry Densham||Nucleic acid sequence analysis|
|WO1999005320A1 *||21 Jul 1998||4 Feb 1999||Rapigene, Inc.||Multiple functionalities within an array element and uses thereof|
|WO1999005321A1 *||21 Jul 1998||4 Feb 1999||Rapigene, Inc.||Amplification and other enzymatic reactions performed on nucleic acid arrays|
|WO1999054497A1 *||22 Abr 1999||28 Oct 1999||Stefan Seeger||Method and device for determining the concentration, adsorption and binding kinetics and equilibrium and binding constants of molecules by luminescence measurements|
|WO1999057321A1 *||30 Abr 1999||11 Nov 1999||Arizona Board Of Regents||Method of determining the nucleotide sequence of oligonucleotides and dna molecules|
|WO2000018956A1 *||29 Sep 1999||6 Abr 2000||Molecular Machines & Industries Gmbh||Method for dna- or rna-sequencing|
|WO2000053805A1 *||10 Mar 2000||14 Sep 2000||Asm Scientific, Inc.||A method for direct nucleic acid sequencing|
|WO2000058507A1 *||30 Mar 2000||5 Oct 2000||Solexa Ltd.||Polynucleotide sequencing|
|WO2000060114A2 *||6 Abr 2000||12 Oct 2000||Medical Biosystems Ltd.||Polynucleotide sequencing using a helicase|
|WO2000060114A3 *||6 Abr 2000||31 Ene 2002||Daniel Henry Densham||Polynucleotide sequencing using a helicase|
|WO2001025480A2 *||6 Oct 2000||12 Abr 2001||Medical Biosystems Ltd.||Dna sequencing method|
|WO2001025480A3 *||6 Oct 2000||16 May 2002||Daniel Henry Densham||Dna sequencing method|
|WO2001032930A1 *||6 Nov 2000||10 May 2001||California Institute Of Technology||Methods and apparatuses for analyzing polynucleotide sequences|
|WO2001057248A2 *||31 Ene 2001||9 Ago 2001||Solexa Ltd.||Polynucleotide arrays and their use in sequencing|
|WO2001057248A3 *||31 Ene 2001||14 Feb 2002||Solexa Ltd||Polynucleotide arrays and their use in sequencing|
|WO2001057249A1 *||1 Feb 2001||9 Ago 2001||Solexa Ltd.||Synthesis of spatially addressed molecular arrays|
|WO2001073121A1 *||30 Mar 2001||4 Oct 2001||Toyota Jidosha Kabushiki Kaisha||Method of determining base sequence of single nucleic acid molecule|
|WO2002002813A2 *||2 Jul 2001||10 Ene 2002||Amersham Biosiences Uk Ltd.||Sequencing method|
|WO2002002813A3 *||2 Jul 2001||13 Mar 2003||Amersham Biosiences Uk Ltd||Sequencing method|
|WO2003073088A2 *||11 Mar 2002||4 Sep 2003||Christofer Toumazou||Apparatus and method for the detection of localised fluctuactions of ionic charge by ion sensitive field effect transistors during a chemical reaction|
|WO2003073088A3 *||11 Mar 2002||20 Nov 2003||Christofer Toumazou||Apparatus and method for the detection of localised fluctuactions of ionic charge by ion sensitive field effect transistors during a chemical reaction|
|WO2004029294A1 *||26 Sep 2003||8 Abr 2004||Biotage Ab||New sequencing method for sequencing rna molecules|
|WO2004072294A2 *||9 Feb 2004||26 Ago 2004||Genizon Svenska Ab||Methods and means for nucleic acid sequencing|
|WO2004072294A3 *||9 Feb 2004||10 Mar 2005||Global Genomics Ab||Methods and means for nucleic acid sequencing|
|WO2004106545A1 *||18 May 2004||9 Dic 2004||Innogenetics N.V.||Methods for enhanced detection using surface sensitive techniques.|
|WO2005118871A1 *||27 May 2005||15 Dic 2005||The Arizona Board Of Regents||Surface plasmon resonance sensor for detecting changes in polynucleotides mass|
|EP1017848B2 †||24 Jul 1998||22 Feb 2012||Gen-Probe Incorporated||Nucleic acid sequence analysis|
|EP1163369A1 *||22 Feb 2000||19 Dic 2001||Caliper Technologies Corporation||Sequencing by incorporation|
|EP1163369A4 *||22 Feb 2000||28 Ago 2002||Caliper Techn Corp||Sequencing by incorporation|
|EP1179085A1 *||18 May 2000||13 Feb 2002||Cornell Research Foundation, Inc.||Method for sequencing nucleic acid molecules|
|EP1179085A4 *||18 May 2000||10 Nov 2004||Cornell Res Foundation Inc||Method for sequencing nucleic acid molecules|
|EP1182267A1 *||30 Mar 2001||27 Feb 2002||Genesis Research Institute, Inc.||Method of determining base sequence of single nucleic acid molecule|
|EP1182267A4 *||30 Mar 2001||15 Sep 2004||Toyota Motor Co Ltd||Method of determining base sequence of single nucleic acid molecule|
|EP1229133A2 *||24 Jul 1998||7 Ago 2002||Medical Biosystems Ltd.||Nucleic acid sequence analysis|
|EP1229133A3 *||24 Jul 1998||13 Oct 2004||Medical Biosystems Ltd.||Nucleic acid sequence analysis|
|EP1681356A1 *||18 May 2000||19 Jul 2006||Cornell Research Foundation, Inc.||Method for sequencing nucleic acid molecules|
|EP1837407A2 *||5 Sep 2002||26 Sep 2007||Intel Corporation||Nucleic acid sequencing by monitoring of uptake of precursors during molecular replication, with molecule dispenser|
|EP1837407A3 *||5 Sep 2002||21 Nov 2007||Intel Corporation||Nucleic acid sequencing by monitoring of uptake of precursors during molecular replication, with molecule dispenser|
|EP1961826A3 *||10 Mar 2000||17 Sep 2008||ASM Scientific, Inc.||A method for direct nucleic acid sequencing|
|EP2177627A1 *||22 Feb 2000||21 Abr 2010||Caliper Life Sciences, Inc.||Manipulation of microparticles in microfluidic systems|
|EP2267164A3 *||24 Jul 1998||15 Ago 2012||Gen-Probe Incorporated||Nucleic acid sequence analysis|
|EP2267165A3 *||24 Jul 1998||10 Oct 2012||Gen-Probe Incorporated||Nucleic acid sequence analysis|
|US5547839 *||6 Dic 1990||20 Ago 1996||Affymax Technologies N.V.||Sequencing of surface immobilized polymers utilizing microflourescence detection|
|US5641634 *||30 Nov 1995||24 Jun 1997||Mandecki; Wlodek||Electronically-indexed solid-phase assay for biomolecules|
|US5736332 *||30 Nov 1995||7 Abr 1998||Mandecki; Wlodek||Method of determining the sequence of nucleic acids employing solid-phase particles carrying transponders|
|US5750337 *||16 Sep 1992||12 May 1998||The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland||Methods for detecting nucleic acid sequences using evanescent wave detection|
|US5902723 *||12 Jul 1996||11 May 1999||Dower; William J.||Analysis of surface immobilized polymers utilizing microfluorescence detection|
|US5908755 *||15 Oct 1997||1 Jun 1999||Sarnoff Corporation||Sequential step method for sequencing and identifying polynucleotides|
|US5981166 *||23 Abr 1997||9 Nov 1999||Pharmaseq, Inc.||Screening of soluble chemical compounds for their pharmacological properties utilizing transponders|
|US6027890 *||22 Jul 1997||22 Feb 2000||Rapigene, Inc.||Methods and compositions for enhancing sensitivity in the analysis of biological-based assays|
|US6046003 *||26 Ene 1998||4 Abr 2000||Pharmaseq, Inc.||Method of determining the sequence of nucleic acids employing solid-phase particles carrying transponders|
|US6051377 *||9 Dic 1996||18 Abr 2000||Pharmaseq, Inc.||Multiplex assay for nucleic acids employing transponders|
|US6087095 *||22 Abr 1993||11 Jul 2000||Medical Research Council||DNA sequencing method|
|US6117634 *||5 Mar 1997||12 Sep 2000||The Reagents Of The University Of Michigan||Nucleic acid sequencing and mapping|
|US6136543 *||31 Ene 1997||24 Oct 2000||Hitachi, Ltd.||Method for determining nucleic acids base sequence and apparatus therefor|
|US6153379 *||22 Jun 1994||28 Nov 2000||Baylor College Of Medicine||Parallel primer extension approach to nucleic acid sequence analysis|
|US6197557||10 Sep 1998||6 Mar 2001||The Regents Of The University Of Michigan||Compositions and methods for analysis of nucleic acids|
|US6242193||9 May 2000||5 Jun 2001||Hitachi, Ltd.||Apparatus for determining base sequence of nucleic acid|
|US6248521||21 Jul 1998||19 Jun 2001||Qiagen Genomics, Inc.||Amplification and other enzymatic reactions performed on nucleic acid arrays|
|US6312893||22 Jul 1997||6 Nov 2001||Qiagen Genomics, Inc.||Methods and compositions for determining the sequence of nucleic acid molecules|
|US6355433||2 Jun 2000||12 Mar 2002||Dna Sciences, Inc.||Determination of nucleotide sequence variations through limited primer extension|
|US6361950||3 Abr 2000||26 Mar 2002||Pharmaseq, Inc.||Multiplex assay for nucleic acids employing transponders|
|US6365349||21 Jul 1998||2 Abr 2002||Qiagen Genomics, Inc.||Apparatus and methods for arraying solution onto a solid support|
|US6376187||11 Jul 2000||23 Abr 2002||Pharmaseq, Inc.||Electronically-indexed solid-phase assay for biomolecules|
|US6387623||29 Mar 2000||14 May 2002||Pharmaseq||Screening of drugs from chemical combinatorial libraries employing transponders|
|US6458544||1 Dic 2000||1 Oct 2002||Dna Sciences, Inc.||Methods for determining single nucleotide variations and genotyping|
|US6511803 *||10 Mar 2000||28 Ene 2003||President And Fellows Of Harvard College||Replica amplification of nucleic acid arrays|
|US6537757||8 Ago 2000||25 Mar 2003||The Regents Of The University Of Michigan||Nucleic acid sequencing and mapping|
|US6573047||11 Abr 2000||3 Jun 2003||Dna Sciences, Inc.||Detection of nucleotide sequence variation through fluorescence resonance energy transfer label generation|
|US6613508||22 Jul 1997||2 Sep 2003||Qiagen Genomics, Inc.||Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques|
|US6613513||22 Feb 2000||2 Sep 2003||Caliper Technologies Corp.||Sequencing by incorporation|
|US6623928||14 May 2001||23 Sep 2003||Qiagen Genomics, Inc.||Methods and compositions for determining the sequence of nucleic acid molecules|
|US6653082||16 May 2002||25 Nov 2003||Baylor College Of Medicine||Substrate-bound cleavage assay for nucleic acid analysis|
|US6686158||17 Jul 2001||3 Feb 2004||Pharma Seg, Inc.||Electronically-indexed solid-phase assay for biomolecules|
|US6762022||6 Mar 2001||13 Jul 2004||The Regents Of The University Of Michigan||Compositions and methods for analysis of nucleic acids|
|US6787308||30 Ene 2001||7 Sep 2004||Solexa Ltd.||Arrayed biomolecules and their use in sequencing|
|US6815212||24 Oct 2001||9 Nov 2004||Qiagen Genomics, Inc.||Methods and compositions for enhancing sensitivity in the analysis of biological-based assays|
|US6818395||6 Nov 2000||16 Nov 2004||California Institute Of Technology||Methods and apparatus for analyzing polynucleotide sequences|
|US6908736||6 Oct 2000||21 Jun 2005||Medical Biosystems, Ltd.||DNA sequencing method|
|US7001722||13 Nov 2000||21 Feb 2006||Baylor College Of Medicine||Parallel primer extension approach to nucleic acid sequence analysis|
|US7008766||24 Jul 1998||7 Mar 2006||Medical Biosystems, Ltd.||Nucleic acid sequence analysis|
|US7033764||15 Dic 2004||25 Abr 2006||Cornell Research Foundation, Inc.||Method for sequencing nucleic acid molecules|
|US7037687||28 Ago 2002||2 May 2006||Arizona Board Of Regents||Method of determining the nucleotide sequence of oligonucleotides and DNA molecules|
|US7052846||19 Jun 2003||30 May 2006||Operon Biotechnologies, Inc.||Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques|
|US7052847||15 Dic 2004||30 May 2006||Cornell Research Foundation, Inc.||Method for sequencing nucleic acid molecules|
|US7056661||17 May 2000||6 Jun 2006||Cornell Research Foundation, Inc.||Method for sequencing nucleic acid molecules|
|US7056666||14 Feb 2002||6 Jun 2006||Affymetrix, Inc.||Analysis of surface immobilized polymers utilizing microfluorescence detection|
|US7056670||2 Jul 2001||6 Jun 2006||Ge Healthcare Uk Limited||Sequencing method|
|US7056676||16 Dic 2004||6 Jun 2006||Cornell Research Foundation, Inc.||Method for sequencing nucleic acid molecules|
|US7105300||14 Abr 2003||12 Sep 2006||Caliper Life Sciences, Inc.||Sequencing by incorporation|
|US7170050||17 Sep 2004||30 Ene 2007||Pacific Biosciences Of California, Inc.||Apparatus and methods for optical analysis of molecules|
|US7223568||30 Nov 2001||29 May 2007||Toyota Jidosha Kabushiki Kaisha||Methods for determining nucleotide sequences of single nucleic acid molecules|
|US7232656||30 Jun 2003||19 Jun 2007||Solexa Ltd.||Arrayed biomolecules and their use in sequencing|
|US7247434||16 Jul 2003||24 Jul 2007||Operon Biotechnologies, Inc.||Methods and compositions for determining the sequence of nucleic acid molecules|
|US7270951||10 Mar 2000||18 Sep 2007||Asm Scientific, Inc.||Method for direct nucleic acid sequencing|
|US7270958||13 Jul 2004||18 Sep 2007||The Regents Of The University Of Michigan||Compositions and methods for analysis of nucleic acids|
|US7302146||16 Sep 2005||27 Nov 2007||Pacific Biosciences Of California, Inc.||Apparatus and method for analysis of molecules|
|US7313308||24 Ene 2007||25 Dic 2007||Pacific Biosciences Of California, Inc.||Optical analysis of molecules|
|US7315019||16 Sep 2005||1 Ene 2008||Pacific Biosciences Of California, Inc.||Arrays of optical confinements and uses thereof|
|US7344865||11 Ago 2006||18 Mar 2008||Caliper Life Sciences, Inc.||Sequencing by incorporation|
|US7361466||25 Mar 2005||22 Abr 2008||Cornell Research Foundation, Inc.||Nucleic acid analysis using terminal-phosphate-labeled nucleotides|
|US7384737||1 Ago 2002||10 Jun 2008||Solexa Limited||Synthesis of spatially addressed molecular arrays|
|US7416844||21 Nov 2005||26 Ago 2008||Cornell Research Foundation, Inc.||Composition for nucleic acid sequencing|
|US7427673||4 Dic 2002||23 Sep 2008||Illumina Cambridge Limited||Labelled nucleotides|
|US7476503||16 Sep 2005||13 Ene 2009||Pacific Biosciences Of California, Inc.||Apparatus and method for performing nucleic acid analysis|
|US7485424||21 Mar 2006||3 Feb 2009||Cornell Research Foundation, Inc.||Labeled nucleotide phosphate (NP) probes|
|US7501245||1 Dic 2004||10 Mar 2009||Helicos Biosciences Corp.||Methods and apparatuses for analyzing polynucleotide sequences|
|US7541444||22 Ago 2003||2 Jun 2009||Illumina Cambridge Limited||Modified nucleotides|
|US7566537||13 Dic 2005||28 Jul 2009||Illumina Cambridge Limited||Labelled nucleotides|
|US7566538||22 Ene 2008||28 Jul 2009||Caliper Lifesciences Inc.||Sequencing by incorporation|
|US7592435||27 Jul 2006||22 Sep 2009||Illumina Cambridge Limited||Modified nucleosides and nucleotides and uses thereof|
|US7642344||21 Jun 2007||5 Ene 2010||Operon Biotechnologies, Inc.||Methods and compositions for determining the sequence of nucleic acid molecules|
|US7686929||11 Mar 2002||30 Mar 2010||Dna Electronics Limited||Sensing apparatus and method|
|US7771973||1 Jun 2009||10 Ago 2010||Illumina Cambridge Limited||Modified nucleotides|
|US7772384||9 Sep 2008||10 Ago 2010||Illumina Cambridge Limited||Labelled nucleotides|
|US7785790||8 May 2007||31 Ago 2010||President And Fellows Of Harvard College||Replica amplification of nucleic acid arrays|
|US7785796||23 Jul 2009||31 Ago 2010||Illumina Cambridge Limited||Labelled nucleotides|
|US7816503||21 Sep 2009||19 Oct 2010||Illumina Cambridge Limited||Modified nucleosides and nucleotides and uses thereof|
|US7888015||2 Mar 2007||15 Feb 2011||Dna Electronics Ltd.||qPCR using solid-state sensing|
|US7906284||26 Oct 2007||15 Mar 2011||Pacific Biosciences Of California, Inc.||Arrays of optical confinements and uses thereof|
|US7939264||22 Feb 2010||10 May 2011||Gen-Probe Incorporated||DNA sequencing method|
|US7943305||13 Abr 2006||17 May 2011||Cornell Research Foundation||High speed nucleic acid sequencing|
|US7943307||19 Ene 2006||17 May 2011||Cornell Research Foundation||Methods for analyzing nucleic acid sequences|
|US8071739||20 Jul 2010||6 Dic 2011||Illumina Cambridge Limited||Modified nucleotides|
|US8114591||23 Ene 2007||14 Feb 2012||Dna Electronics Ltd.||Sensing apparatus and method|
|US8148064||19 Jul 2010||3 Abr 2012||Illumina Cambridge Limited||Labelled nucleotides|
|US8158346||13 Jul 2010||17 Abr 2012||Illumina Cambridge Limited||Labelled nucleotides|
|US8192961||24 Oct 2007||5 Jun 2012||Pacific Biosciences Of California, Inc.||System and methods for nucleic acid sequencing of single molecules by polymerase synthesis|
|US8212015||6 Oct 2010||3 Jul 2012||Illumina Cambridge Limited||Modified nucleosides and nucleotides and uses thereof|
|US8263364||18 Ene 2011||11 Sep 2012||Arizona Board Of Regents||Method of determining the nucleotide sequence of oligonucleotides and DNA molecules|
|US8263365||18 Ene 2011||11 Sep 2012||Arizona Board Of Regents||Method of determining the nucleotide sequence of oligonucleotides and DNA molecules|
|US8394586||28 Mar 2012||12 Mar 2013||Illumina Cambridge Limited||Labelled nucleotides|
|US8399188||4 Sep 2007||19 Mar 2013||Illumina, Inc.||Compositions and methods for nucleotide sequencing|
|US8597881||25 Oct 2011||3 Dic 2013||Illumina Cambridge Limited||Modified nucleotides|
|US8685228||23 Feb 2010||1 Abr 2014||Dna Electronics Limited||Sensing apparatus and method|
|US8698211||17 Ene 2012||15 Abr 2014||Dna Electronics Ltd.||Sensing apparatus and method|
|US8808988||18 Mar 2013||19 Ago 2014||Illumina, Inc.||Compositions and methods for nucleotide sequencing|
|US8911972||14 Dic 2010||16 Dic 2014||Pacific Biosciences Of California, Inc.||Sequencing methods using enzyme conformation|
|US8980584||24 Oct 2007||17 Mar 2015||Pacific Biosciences Of California, Inc.||System and methods for nucleic acid sequencing of single molecules by polymerase synthesis|
|US8993230||4 Dic 2008||31 Mar 2015||Pacific Biosciences of Californ, Inc.||Asynchronous sequencing of biological polymers|
|US9012144||18 Ene 2011||21 Abr 2015||Fluidigm Corporation||Short cycle methods for sequencing polynucleotides|
|US9051612||10 Jul 2014||9 Jun 2015||Illumina, Inc.||Compositions and methods for nucleotide sequencing|
|US9096898||16 Dic 2010||4 Ago 2015||Life Technologies Corporation||Method of determining the nucleotide sequence of oligonucleotides and DNA molecules|
|US9115163||17 Oct 2008||25 Ago 2015||The Trustees Of Columbia University In The City Of New York||DNA sequence with non-fluorescent nucleotide reversible terminators and cleavable label modified nucleotide terminators|
|US9121060||8 Mar 2013||1 Sep 2015||Illumina Cambridge Limited||Modified nucleotides|
|US9121062||2 Dic 2013||1 Sep 2015||Illumina Cambridge Limited||Labelled nucleotides|
|US9127314||6 Nov 2013||8 Sep 2015||Illumina Cambridge Limited||Labelled nucleotides|
|US9133511||5 Ago 2013||15 Sep 2015||The Trustees Of Columbia University In The City Of New York||Massive parallel method for decoding DNA and RNA|
|US9175342||25 Jul 2013||3 Nov 2015||The Trustees Of Columbia University In The City Of New York||Synthesis of cleavable fluorescent nucleotides as reversible terminators for DNA sequencing by synthesis|
|US9212393||3 May 2011||15 Dic 2015||Life Technologies Corporation||Method of determining the nucleotide sequence of oligonucleotides and DNA molecules|
|US9243284||20 Dic 2013||26 Ene 2016||Life Technologies Corporation||Enzymatic nucleic acid synthesis: compositions and methods for inhibiting pyrophosphorolysis|
|US9388463||8 Mar 2013||12 Jul 2016||Illumina Cambridge Limited||Labelled nucleotides|
|US9388464||7 Ago 2015||12 Jul 2016||Illumina Cambridge Limited||Modified nucleotides|
|US9410199||7 Ago 2015||9 Ago 2016||Illumina Cambridge Limited||Labelled nucleotides|
|US9410200||17 Sep 2015||9 Ago 2016||Illumina Cambridge Limited||Labelled nucleotides|
|US9458500||8 Jun 2013||4 Oct 2016||Life Technologies Corporation||Method of determining the nucleotide sequence of oligonucleotides and DNA molecules|
|US9469873||24 Abr 2015||18 Oct 2016||Illumina, Inc.||Compositions and methods for nucleotide sequencing|
|US9528151||1 Abr 2014||27 Dic 2016||The Trustees Of Columbia University In The City Of New York||Four-color DNA sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators|
|US9540689||13 Nov 2015||10 Ene 2017||Life Technologies Corporation||Method of determining the nucleotide sequence of oligonucleotides and DNA molecules|
|US9588051||11 Sep 2015||7 Mar 2017||Pacific Biosciences Of California, Inc.||Apparatus and method for performing nucleic acid analysis|
|US9605310||7 Ago 2015||28 Mar 2017||Illumina Cambridge Limited||Labelled nucleotides|
|US9657344||19 Mar 2015||23 May 2017||Fluidigm Corporation||Short cycle methods for sequencing polynucleotides|
|US9670539||21 Sep 2015||6 Jun 2017||The Trustees Of Columbia University In The City Of New York||Synthesis of cleavable fluorescent nucleotides as reversible terminators for DNA sequencing by synthesis|
|US9708358||15 Dic 2016||18 Jul 2017||The Trustees Of Columbia University In The City Of New York||Massive parallel method for decoding DNA and RNA|
|US9709503||19 Ago 2016||18 Jul 2017||Pacific Biosciences Of California, Inc.||Apparatus and method for performing nucleic acid analysis|
|US9718852||15 Dic 2016||1 Ago 2017||The Trustees Of Columbia University In The City Of New York||Massive parallel method for decoding DNA and RNA|
|US9719139||15 Dic 2016||1 Ago 2017||The Trustees Of Columbia University In The City Of New York||Massive parallel method for decoding DNA and RNA|
|US9725480||27 May 2016||8 Ago 2017||The Trustees Of Columbia University In The City Of New York||Massive parallel method for decoding DNA and RNA|
|US9725764||2 Sep 2016||8 Ago 2017||Life Technologies Corporation||Method of determining the nucleotide sequence of oligonucleotides and DNA molecules|
|Clasificación internacional||G01N33/53, C12Q1/68|
|Clasificación cooperativa||C12Q1/6825, C12Q1/6869|
|Clasificación europea||C12Q1/68E, C12Q1/68B2H|
|15 Nov 1990||AL||Designated countries for regional patents|
Kind code of ref document: A1
Designated state(s): AT BE CH DE DK ES FR GB IT LU NL SE
|15 Nov 1990||AK||Designated states|
Kind code of ref document: A1
Designated state(s): CA JP US
|14 Jun 1991||WWE||Wipo information: entry into national phase|
Ref document number: 1990907267
Country of ref document: EP
|4 Jul 1991||WWE||Wipo information: entry into national phase|
Ref document number: 2045505
Country of ref document: CA
|4 Jul 1991||ENP||Entry into the national phase in:|
Ref country code: CA
Ref document number: 2045505
Kind code of ref document: A
Format of ref document f/p: F
|26 Feb 1992||WWP||Wipo information: published in national office|
Ref document number: 1990907267
Country of ref document: EP
|28 May 1993||WWW||Wipo information: withdrawn in national office|
Ref document number: 1990907267
Country of ref document: EP